Hydroxyzine Imine Market

Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central nervous system. This property aids hydroxyzine imine to treat anxiety and tension associated with psychoneurosis. Besides, it also acts as an antihistamine which reduces the actions of natural histamine in the body and hence can cure symptoms of itching, or hives on the skin.

Hydroxyzine Imine Market contains market size and forecasts of Hydroxyzine Imine in Global, including the following market information:

• Global Hydroxyzine Imine Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Hydroxyzine Imine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hydroxyzine Imine include Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries, Shanghai Ruizheng Chemical Technology Co., Ltd, Lupin Pharmaceuticals, Inc., N&R Industries, OAK PHARMS INC., Changzhou ComWin Fine Chemicals Co., Ltd and Novartis International AG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hydroxyzine Imine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hydroxyzine Imine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hydroxyzine Imine Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Capsule
• Syrup
• Injection

Global Hydroxyzine Imine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hydroxyzine Imine Market Segment Percentages, by Application, 2021 (%)

• Urticaria
• Histamine-Mediated Pruritus and Atopic
• Contact Dermatoses

Global Hydroxyzine Imine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hydroxyzine Imine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hydroxyzine Imine revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Hydroxyzine Imine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc.
• GlaxoSmithKline plc
• Teva Pharmaceutical Industries
• Shanghai Ruizheng Chemical Technology Co., Ltd
• Lupin Pharmaceuticals, Inc.
• N&R Industries
• OAK PHARMS INC.
• Changzhou ComWin Fine Chemicals Co., Ltd
• Novartis International AG
• Impax Laboratories, Inc